These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Early alteration induced by tumor promoters on chick embryo muscle cells in culture.
    Author: Zani BM, Molinaro M.
    Journal: Prog Clin Biol Res; 1982; 85 Pt B():403-14. PubMed ID: 7122574.
    Abstract:
    When differentiated, multinucleated cultured myotubes are treated with PMA (Phorbol-12-myristate-13-acetate), they display drastic morphological alterations and undergo inhibition of the expression of differentiative traits, without being induced to reenter the cell cycle. Differentiated myotubes, obtained after cytochalasin B treatment of primary chick embryo myoblast cultures, were treated with 1.6 x 10(7) M PMA for different times, labelled with 35S-methionine and different fractions of cell extracts were analysed by SDS-PAGE followed by fluorography. The data presented here indicate that PMA treatment induces in myotubes increased synthesis of a 31.000 Mr polypeptide (31 K) within 4 hr of treatment, while the inhibition of the synthesis of contractile proteins, such as myosin and actin, occurs only after 8 hr of treatment. Morphological alterations of myotubes require longer incubation with PMA (15-20 hr). The reported effects of PMA are not induced by non tumor promotor analogs of the drug, and pulse chase experiments indicate that 31 K stimulation is not the result of increased protein degradation induced by PMA. In addition the stimulation of 31K does not occur in cultured fibroblast indicating that this is a specific early response of differentiated myogenic cells preceeding the dedifferentiative effect of this tumor promotor.
    [Abstract] [Full Text] [Related] [New Search]